高级检索
    张馨予, 徐卫, 刘思初. 苯达莫司汀联合利妥昔单抗与R-CHOP方案一线治疗惰性非霍奇金淋巴瘤或套细胞淋巴瘤疗效及安全性比较[J]. 循证医学, 2016, 16(2): 73-75. DOI: 10.12019/j.issn.1671-5144.2016.02.005
    引用本文: 张馨予, 徐卫, 刘思初. 苯达莫司汀联合利妥昔单抗与R-CHOP方案一线治疗惰性非霍奇金淋巴瘤或套细胞淋巴瘤疗效及安全性比较[J]. 循证医学, 2016, 16(2): 73-75. DOI: 10.12019/j.issn.1671-5144.2016.02.005
    shu
    ZHANG Xin-yu, XU Wei, LIU Si-chu. Efficacy and Safety of Bendamustine plus Rituximab Compared with CHOP plus Rituximab as First-Line Treatment for Patients with Indolent Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma[J]. Journal of Evidence-Based Medicine, 2016, 16(2): 73-75. DOI: 10.12019/j.issn.1671-5144.2016.02.005
    Citation: ZHANG Xin-yu, XU Wei, LIU Si-chu. Efficacy and Safety of Bendamustine plus Rituximab Compared with CHOP plus Rituximab as First-Line Treatment for Patients with Indolent Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma[J]. Journal of Evidence-Based Medicine, 2016, 16(2): 73-75. DOI: 10.12019/j.issn.1671-5144.2016.02.005
    shu

    苯达莫司汀联合利妥昔单抗与R-CHOP方案一线治疗惰性非霍奇金淋巴瘤或套细胞淋巴瘤疗效及安全性比较

    Efficacy and Safety of Bendamustine plus Rituximab Compared with CHOP plus Rituximab as First-Line Treatment for Patients with Indolent Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回